Adalimumab is a monoclonal TNF inhibitor used to treat various autoimmune disorders, including rheumatoid arthritis, ankylosing spondylitis, and psoriasis. It works by blocking the action of tumor necrosis factor-alpha (TNF-α), a key mediator of inflammation. Adalimumab's clinical relevance lies in its ability to reduce inflammation and improve quality of life for patients with chronic inflammatory conditions. In summary, Adalimumab is a targeted therapy for managing autoimmune diseases.
Adalimumab binds to TNF-α, inhibiting its interaction with receptors and preventing downstream inflammatory signaling.
No published brands for this salt yet.